Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tcr2 Therapeutics Inc. (TCRR) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tcr2 Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1750019.
Total stock buying since 2019: $65,685,844.
Total stock sales since 2019: $16,752,850.
Total stock option exercises since 2019: $319,617.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 468,513 | $885,859 | 140,340 | $263,838 | 0 | $0 |
| 2022 | 0 | $0 | 112,938 | $138,278 | 409,428 | $0 |
| 2021 | 0 | $0 | 0 | $0 | 224,752 | $261,317 |
| 2020 | 0 | $0 | 125,306 | $1,589,155 | 51,000 | $58,300 |
| 2019 | 4,319,999 | $64,799,985 | 850,660 | $14,761,579 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-05 | 468,513 | $885,859 | 140,340 | $263,838 | 0 | $0 |
| 2022-12 | 0 | $0 | 112,938 | $138,278 | 409,428 | $0 |
| 2021-12 | 0 | $0 | 0 | $0 | 218,000 | $161,320 |
| 2021-04 | 0 | $0 | 0 | $0 | 6,752 | $99,997 |
| 2020-12 | 0 | $0 | 2,000 | $70,000 | 9,000 | $16,940 |
| 2020-11 | 0 | $0 | 23,666 | $611,980 | 22,000 | $26,560 |
| 2020-10 | 0 | $0 | 20,000 | $382,000 | 20,000 | $14,800 |
| 2020-03 | 0 | $0 | 79,640 | $525,175 | 0 | $0 |
| 2019-12 | 0 | $0 | 366,347 | $6,145,933 | 0 | $0 |
| 2019-10 | 0 | $0 | 3,888 | $58,930 | 0 | $0 |
| 2019-09 | 0 | $0 | 439,094 | $7,853,717 | 0 | $0 |
| 2019-08 | 0 | $0 | 41,331 | $702,999 | 0 | $0 |
| 2019-02 | 4,319,999 | $64,799,985 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-25 | Tang Capital Partners Lp (10% Owner) | Buy | 50,000 | 1.72 | 86,000 |
| 2023-05-22 | Evnin Luke (10% Owner) | Sale | 70,170 | 1.88 | 131,919 |
| 2023-05-22 | Gadicke Ansbert (Director) | Sale | 70,170 | 1.88 | 131,919 |
| 2023-05-12 | Tang Capital Partners Lp (10% Owner) | Buy | 6,183 | 1.95 | 12,056 |
| 2023-05-11 | Tang Capital Partners Lp (10% Owner) | Buy | 38,765 | 1.95 | 75,591 |
| 2023-05-10 | Tang Capital Partners Lp (10% Owner) | Buy | 6,774 | 1.95 | 13,209 |
| 2023-05-09 | Tang Capital Partners Lp (10% Owner) | Buy | 20,141 | 1.95 | 39,274 |
| 2023-05-08 | Tang Capital Partners Lp (10% Owner) | Buy | 57,073 | 1.95 | 111,292 |
| 2023-05-05 | Tang Capital Partners Lp (10% Owner) | Buy | 166,823 | 1.92 | 320,300 |
| 2023-05-04 | Tang Capital Partners Lp (10% Owner) | Buy | 104,241 | 1.86 | 193,888 |
| 2023-05-03 | Tang Capital Partners Lp (10% Owner) | Buy | 18,513 | 1.85 | 34,249 |
| 2022-12-13 | Olagunju Peter (Chief Technical Officer) | Sale | 1,659 | 1.06 | 1,766 |
| 2022-12-13 | Cardama Alfonso Quintas (Chief Medical Officer) | Sale | 4,752 | 1.06 | 5,041 |
| 2022-12-13 | Menzel Garry E (President and CEO) | Sale | 11,000 | 1.06 | 11,682 |
| 2022-12-12 | Olagunju Peter (Chief Technical Officer) | Sale | 1,610 | 1.10 | 1,766 |
| 2022-12-12 | Cardama Alfonso Quintas (Chief Medical Officer) | Sale | 4,586 | 1.10 | 5,040 |
| 2022-12-12 | Justice Angela (Chief People Officer) | Sale | 5,828 | 1.08 | 6,300 |
| 2022-12-12 | Menzel Garry E (President and CEO) | Sale | 10,613 | 1.10 | 11,674 |
| 2022-12-09 | Olagunju Peter (Chief Technical Officer) | Sale | 1,561 | 1.13 | 1,765 |
| 2022-12-09 | Cardama Alfonso Quintas (Chief Medical Officer) | Sale | 4,461 | 1.13 | 5,040 |
| 2022-12-09 | Justice Angela (Chief People Officer) | Sale | 2,792 | 1.13 | 3,149 |
| 2022-12-09 | Menzel Garry E (President and CEO) | Sale | 10,325 | 1.13 | 11,677 |
| 2022-12-06 | Olagunju Peter (Chief Technical Officer) | Sale | 1,327 | 1.33 | 1,764 |
| 2022-12-06 | Cardama Alfonso Quintas (Chief Medical Officer) | Sale | 3,778 | 1.33 | 5,039 |
| 2022-12-06 | Justice Angela (Chief People Officer) | Sale | 2,361 | 1.33 | 3,149 |
| 2022-12-06 | Menzel Garry E (President and CEO) | Sale | 14,886 | 1.35 | 20,081 |
| 2022-12-05 | Olagunju Peter (Chief Technical Officer) | Sale | 1,291 | 1.37 | 1,766 |
| 2022-12-05 | Cardama Alfonso Quintas (Chief Medical Officer) | Sale | 3,686 | 1.37 | 5,049 |
| 2022-12-05 | Justice Angela (Chief People Officer) | Sale | 2,302 | 1.37 | 3,160 |
| 2022-12-05 | Menzel Garry E (President and CEO) | Sale | 8,530 | 1.37 | 11,703 |
| 2022-12-02 | Olagunju Peter (Chief Technical Officer) | Sale | 1,273 | 1.39 | 1,765 |
| 2022-12-02 | Cardama Alfonso Quintas (Chief Medical Officer) | Sale | 3,636 | 1.39 | 5,054 |
| 2022-12-02 | Justice Angela (Chief People Officer) | Sale | 2,273 | 1.39 | 3,161 |
| 2022-12-02 | Menzel Garry E (President & CEO) | Sale | 8,408 | 1.39 | 11,687 |
| 2022-12-01 | Olagunju Peter (Chief Technical Officer) | Option Ex | 33,409 | .00 | 0 |
| 2022-12-01 | Cardama Alfonso Quintas (Chief Medical Officer) | Option Ex | 95,385 | .00 | 0 |
| 2022-12-01 | Justice Angela (Chief People Officer) | Option Ex | 59,576 | .00 | 0 |
| 2022-12-01 | Menzel Garry E (President & CEO) | Option Ex | 221,058 | .00 | 0 |
| 2021-12-09 | Cardama Alfonso Quintas (Chief Medical Officer) | Option Ex | 43,000 | .74 | 31,820 |
| 2021-12-09 | Menzel Garry E (President & CEO) | Option Ex | 175,000 | .74 | 129,500 |
| 2021-04-02 | Justice Angela (Chief People Officer) | Option Ex | 6,752 | 14.81 | 99,997 |
| 2020-12-22 | Hofmeister Robert (Chief Scientific Officer) | Option Ex | 7,000 | .74 | 5,180 |
| 2020-12-14 | Somaiya Mayur Ian (Chief Financial Officer) | Sale | 2,000 | 35.00 | 70,000 |
| 2020-12-14 | Somaiya Mayur Ian (Chief Financial Officer) | Option Ex | 2,000 | 5.88 | 11,760 |
| 2020-11-17 | Somaiya Mayur Ian (Chief Financial Officer) | Sale | 3,666 | 30.00 | 109,980 |
| 2020-11-17 | Somaiya Mayur Ian (Chief Financial Officer) | Option Ex | 2,000 | 5.88 | 11,760 |
| 2020-11-12 | Hofmeister Robert (Chief Scientific Officer) | Sale | 20,000 | 25.10 | 502,000 |
| 2020-11-12 | Hofmeister Robert (Chief Scientific Officer) | Option Ex | 20,000 | .74 | 14,800 |
| 2020-10-29 | Hofmeister Robert (Chief Science Officer) | Sale | 20,000 | 19.10 | 382,000 |
| 2020-10-29 | Hofmeister Robert (Chief Science Officer) | Option Ex | 20,000 | .74 | 14,800 |
| 2020-03-20 | Gibson Neil W (Director) | Sale | 648 | 7.94 | 5,145 |
| 2020-03-19 | Gibson Neil W (Director) | Sale | 3,140 | 7.41 | 23,267 |
| 2020-03-18 | Gibson Neil W (Director) | Sale | 3,120 | 6.83 | 21,309 |
| 2020-03-17 | Gibson Neil W (Director) | Sale | 3,009 | 6.49 | 19,528 |
| 2020-03-16 | Gibson Neil W (Director) | Sale | 17,723 | 6.60 | 117,042 |
| 2020-03-13 | Gibson Neil W (Director) | Sale | 52,000 | 6.52 | 338,884 |
| 2019-12-23 | Baeuerle Patrick (Director) | Sale | 84,907 | 15.44 | 1,310,964 |
| 2019-12-20 | Baeuerle Patrick (Director) | Sale | 32,022 | 15.16 | 485,453 |
| 2019-12-19 | F2 Capital I 2019, Llc (10% Owner) | Sale | 41,965 | 16.47 | 691,205 |
| 2019-12-18 | F2 Capital I 2019, Llc (10% Owner) | Sale | 2,891 | 17.01 | 49,164 |
| 2019-12-11 | F2 - Tpo Investments Llc (10% Owner) | Sale | 7,743 | 17.65 | 136,687 |
| 2019-12-10 | F2 - Tpo Investments Llc (10% Owner) | Sale | 56,830 | 17.62 | 1,001,515 |
| 2019-12-09 | F2 - Tpo Investments Llc (10% Owner) | Sale | 139,989 | 17.65 | 2,470,945 |
| 2019-10-22 | F2 - Tpo Investments Llc (10% Owner) | Sale | 3,888 | 15.16 | 58,930 |
| 2019-09-23 | F2 Capital I 2019, Llc (10% Owner) | Sale | 11,321 | 17.31 | 195,977 |
| 2019-09-20 | F2 Capital I 2019, Llc (10% Owner) | Sale | 405,000 | 17.93 | 7,263,674 |
| 2019-09-04 | F2 Capital I 2019, Llc (10% Owner) | Sale | 12,214 | 17.55 | 214,416 |
| 2019-09-03 | F2 Capital I 2019, Llc (10% Owner) | Sale | 10,559 | 17.01 | 179,650 |
| 2019-08-29 | F2 Capital I 2019, Llc (10% Owner) | Sale | 3,700 | 17.01 | 62,925 |
| 2019-08-28 | F2 Capital I 2019, Llc (10% Owner) | Sale | 6,700 | 17.01 | 113,940 |
| 2019-08-27 | F2 Capital I 2019, Llc (10% Owner) | Sale | 1,200 | 17.01 | 20,413 |
| 2019-08-26 | F2 Capital I 2019, Llc (10% Owner) | Sale | 29,128 | 17.01 | 495,467 |
| 2019-08-23 | F2 Capital I 2019, Llc (10% Owner) | Sale | 3 | 17.00 | 51 |
| 2019-08-22 | F2 Capital I 2019, Llc (10% Owner) | Sale | 100 | 17.03 | 1,703 |
| 2019-08-21 | F2 Capital I 2019, Llc (10% Owner) | Sale | 500 | 17.00 | 8,500 |
| 2019-02-19 | China Molybdenum (hong Kong) Co Ltd (10% Owner) | Buy | 200,000 | 15.00 | 3,000,000 |
| 2019-02-19 | F2 Capital I 2019, Llc (10% Owner) | Buy | 666,667 | 15.00 | 10,000,005 |
| 2019-02-19 | Mpm Sunstates Gp Managing Member Llc (10% Owner) | Buy | 706,666 | 15.00 | 10,599,990 |
| 2019-02-19 | Mpm Oncology Impact Management Gp Llc (10% Owner) | Buy | 666,667 | 15.00 | 10,000,005 |
| 2019-02-19 | Mpm Asset Management Llc (10% Owner) | Buy | 706,666 | 15.00 | 10,599,990 |
| 2019-02-19 | Gadicke Ansbert (Director) | Buy | 1,373,333 | 15.00 | 20,599,995 |
Insider trading activities including stock purchases, stock sales, and option exercises of TCRR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tcr2 Therapeutics Inc. (symbol TCRR, CIK number 1750019) see the Securities and Exchange Commission (SEC) website.